Status:
COMPLETED
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The study is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control in patients using a modern insulin: NovoRapid®, NovoMix® 30 or Levemir® for the treatment...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes
- Patients treated with human soluble insulin, NPH insulin or premixed human insulin
- Patients willing to sign informed consent
- Selection of study participants at the discretion of the physician
Exclusion
- Subjects currently being treated with insulin aspart, insulin detemir or biphasic insulin aspart 30
- Subjects who were previously enrolled in this study
- Subjects with a hypersensitivity to insulin aspart, insulin detemir or biphasic insulin aspart 30 or to any of the excipients
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
3809 Patients enrolled
Trial Details
Trial ID
NCT00676741
Start Date
February 1 2008
End Date
May 1 2010
Last Update
October 31 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Bratislava, Slovakia, 811 05